What is the intrinsic value of CPMD?
As of 2025-07-16, the Intrinsic Value of CannaPharmaRx Inc (CPMD) is
0.01 USD. This CPMD valuation is based on the model Peter Lynch Fair Value.
With the current market price of 0.00 USD, the upside of CannaPharmaRx Inc is
174.09%.
Is CPMD undervalued or overvalued?
Based on its market price of 0.00 USD and our intrinsic valuation, CannaPharmaRx Inc (CPMD) is undervalued by 174.09%.
CPMD Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
0.01 - 0.01 |
0.01 |
174.09% |
| P/E |
0.01 - 0.03 |
0.01 |
288.5% |
| DDM - Stable |
0.01 - 0.03 |
0.02 |
407.5% |
| DDM - Multi |
0.02 - 0.07 |
0.04 |
848.4% |
CPMD Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
2.52 |
| Beta |
-0.70 |
| Outstanding shares (mil) |
662.50 |
| Enterprise Value (mil) |
10.97 |
| Market risk premium |
4.60% |
| Cost of Equity |
11.91% |
| Cost of Debt |
5.00% |
| WACC |
5.72% |